Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2025-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Corestemchemon Co., Ltd. It contains the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and information regarding electronic voting and proxy procedures. This document is a formal notice sent to shareholders to provide information and request votes for the upcoming Annual General Meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2025-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement) and contains information regarding the upcoming Annual General Meeting (AGM), including the meeting date, agenda items, and instructions for shareholders to exercise their voting rights via proxy or electronic voting. This document is a standard proxy solicitation material sent to shareholders to request their votes for the meeting.
2025-03-13 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with the KOSDAQ Association's 'concentrated' dates, citing audit and operational schedules. Since this is a specific regulatory disclosure regarding meeting logistics and compliance with corporate governance guidelines rather than the meeting materials themselves or a proxy solicitation, it falls under the general regulatory filing category.
2025-03-13 Korean
기타시장안내 (연구개발 우수기업 매출액 특례적용 관련)
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice from the KOSDAQ market regarding a company's compliance with specific listing rules (revenue exemption for R&D-focused biotech companies). It does not contain financial statements, annual reports, or meeting materials, but rather serves as a formal regulatory announcement regarding market status. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2025-02-27 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Corestemchemon. It outlines the date, location, and specific agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, election of directors, and appointment of auditors. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2025-02-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in accordance with Article 147 of the Capital Markets Act in South Korea. It details changes in share ownership by a major shareholder (Kyung Suk Kim) and special related parties in the company 'Corestemchemone Co., Ltd.' (코아스템켐온 주식회사). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2025-01-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.